Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
AIPPI Congress (Report 2): Ethics in Funding IP Litigation AIPPI Congress (Report 2): Ethics in Funding IP Litigation Reviewed by Annsley Merelle Ward on Wednesday, September 14, 2022 Rating: 5
Book Review: Mechanisms to Enable Follow-On Innovation Book Review: Mechanisms to Enable Follow-On Innovation Reviewed by Anastasiia Kyrylenko on Wednesday, September 14, 2022 Rating: 5
Defining a medical device as a product-by-process (T 1869/19) Defining a medical device as a product-by-process (T 1869/19) Reviewed by Dr Rose Hughes on Wednesday, September 14, 2022 Rating: 5
Guest Book Review: IP Accidents Guest Book Review: IP Accidents Reviewed by Hayleigh Bosher on Wednesday, September 14, 2022 Rating: 5
Another shot for Rango (but, incidentally, the “fair use” defence in Italy has been shot too): Rome Appeal Court confirms there is no misappropriation nor infringement of the “Man With No Name” character Another shot for Rango (but, incidentally, the “fair use” defence in Italy has been shot too): Rome Appeal Court confirms there is no misappropriation nor infringement of the “Man With No Name” character Reviewed by Gabriele Girardello on Monday, September 12, 2022 Rating: 5
“TAKE FIVE” – the EUIPO Board of Appeal maintains that the slogan is not sufficiently distinctive for registration “TAKE FIVE” – the EUIPO Board of Appeal maintains that the slogan is not sufficiently distinctive for registration Reviewed by James Kwong on Monday, September 12, 2022 Rating: 5
AIPPI Congress (Report 1): Is IP the "bogeyman" in access to Covid-19 vaccines? AIPPI Congress (Report 1): Is IP the "bogeyman" in access to Covid-19 vaccines? Reviewed by Annsley Merelle Ward on Sunday, September 11, 2022 Rating: 5
Position mark consisting of grey tread and outer portion of a tyre devoid of distinctive character for tyres, says EUIPO Board of Appeal Position mark consisting of grey tread and outer portion of a tyre devoid of distinctive character for tyres, says EUIPO Board of Appeal Reviewed by Nedim Malovic on Sunday, September 11, 2022 Rating: 5
Advertising Regulatory Board NPC & others v Bliss Brands (Pty) Ltd: Advertising regulatory code's constitutional dimensions clarified Advertising Regulatory Board NPC & others v Bliss Brands (Pty) Ltd: Advertising regulatory code's constitutional dimensions clarified Reviewed by Chijioke Okorie on Saturday, September 10, 2022 Rating: 5
[Guest post] 'Can't Be Evil' NFT license - A tentative NFT worldwide license standard [Guest post] 'Can't Be Evil' NFT license - A tentative NFT worldwide license standard Reviewed by Eleonora Rosati on Monday, September 05, 2022 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.